Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 183 entries
View as:

Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05699070 Org: User:
Start: 02/15/23 End: 06/01/23 Due: 06/01/24

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT04341454 Org: User:
Start: 06/02/20 End: 09/16/21 Due: 09/16/22

Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT02568150 Org: User:
Start: 02/28/14 End: 03/31/14 Due: 03/31/15

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

Phase: N/A Priority: Normal
NCT ID: NCT02502721 Org: User:
Start: 06/30/15 End: 08/31/15 Due: 08/31/16

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT04634500 Org: User:
Start: 11/18/20 End: 11/03/21 Due: 11/03/22

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01415466 Org: User:
Start: 08/31/11 End: 10/31/11 Due: 10/31/12

Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

Phase: N/A Priority: Normal
NCT ID: NCT05816681 Org: User:
Start: 08/22/22 End: 04/10/23 Due: 04/10/24

A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05466643 Org: User:
Start: 03/17/23 End: 09/30/24 Due: 09/30/25

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04888728 Org: User:
Start: 06/30/21 End: 07/27/21 Due: 07/27/22

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.

Phase: N/A Priority: Normal
NCT ID: NCT02418130 Org: User:
Start: 10/31/14 End: 03/31/15 Due: 03/31/16

Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT06948487 Org: User:
Start: 06/04/25 End: 06/03/27 Due: 06/03/28

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin

Phase: N/A Priority: Normal
NCT ID: NCT05376969 Org: User:
Start: 05/25/21 End: 05/16/22 Due: 05/16/23

Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

Phase: N/A Priority: Normal
NCT ID: NCT02946450 Org: User:
Start: 03/31/14 End: - Due: -

Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03029533 Org: User:
Start: 02/28/17 End: - Due: -

Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Phase: N/A Priority: Normal
NCT ID: NCT03946592 Org: User:
Start: 05/15/19 End: 07/02/20 Due: 07/02/21

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02089399 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04782505 Org: User:
Start: 03/12/21 End: 06/28/21 Due: 06/28/22

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT05747664 Org: User:
Start: 04/13/23 End: 04/30/24 Due: 04/30/25

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

Phase: N/A Priority: Normal
NCT ID: NCT05465668 Org: User:
Start: 07/22/22 End: 11/22/22 Due: 11/22/23

Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01629212 Org: User:
Start: 12/31/11 End: 02/28/13 Due: 02/28/14

Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT01557010 Org: User:
Start: 03/31/12 End: 12/31/13 Due: 12/31/14

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03016520 Org: User:
Start: 01/09/17 End: 03/31/17 Due: 03/31/18

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03487562 Org: User:
Start: 04/08/18 End: 01/11/19 Due: 01/11/20

Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02490111 Org: User:
Start: 05/31/15 End: 01/31/18 Due: 01/31/19

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT06212960 Org: User:
Start: 11/28/23 End: 03/21/24 Due: 03/21/25